Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

SHE:300957 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	5,532	5,359	5,736	5,727	5,014	4,022
Revenue Growth	6.74%	-6.58%	0.15%	14.23%	24.65%	52.57%
Gross Profit Gross Profit Growth	4,095	3,955	4,170	4,266	3,752	3,045
Operating Income Operating Income Growth	510.72	475.48	420.76	883.6	1,052	948.45
Net Income Net Income Growth	543.66	505.72	503.05	756.8	1,051	862.92
Earnings Per Share EPS Growth	1.29	1.20	1.20	1.79	2.48	2.12
EPS Growth	51.83%	0%	-32.96%	-27.82%	16.98%	40.40%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Skin Care Products Skin Care Products Growth	4,575	4,801	4,870	4,557	3,629
Makeup Makeup Growth	471.51	550.52	168.62	53.15	53.07
Medical Devices Medical Devices Growth	264.83	354.95	463.11	387.45	325.85
Unallocated Service and Others Unallocated Service and Others Growth	47.04	29.11	20.55	16.12	14.63
Total Total Growth	5,359	5,736	5,522	5,014	4,022

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	3,897	4,308	4,239	3,640	4,428	4,346
Total Debt Total Debt Growth	736.91	834.5	817.77	213.9	113.36	125.2
Net Cash (Debt) Net Cash Growth	3,160	3,474	3,421	3,426	4,315	4,221
Net Cash Growth	1.11%	1.54%	-0.14%	-20.60%	2.23%	461.28%
Net Cash Per Share Net Cash Per Share Growth	7.50	8.24	8.16	8.10	10.18	10.37

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	851.44	976.6	694.87	610.44	769.45	1,153
Capital Expenditures CapEx Growth	-93.58	-482.99	-378.38	-274.28	-353.42	-270.68
Free Cash Flow Free Cash Flow Growth	757.86	493.61	316.48	336.16	416.02	882.04
Free Cash Flow Growth	33.27%	55.97%	-5.85%	-19.20%	-52.83%	158.23%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	74.03%	73.80%	72.71%	74.48%	74.83%	75.71%
Operating Margin	9.23%	8.87%	7.34%	15.43%	20.99%	23.58%
Pretax Margin	11.63%	11.51%	10.61%	15.17%	24.21%	25.31%
Profit Margin	9.83%	9.44%	8.77%	13.21%	20.97%	21.45%
FCF Margin	13.70%	9.21%	5.52%	5.87%	8.30%	21.93%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Dividend Per Share Dividend Per Share Growth	0.500	0.650	0.600	0.600	0.800	0.600
Dividend Per Share Growth	0%	8.33%	-0.08%	-24.94%	33.33%	33.33%
Dividend Yield	1.69%	1.65%	1.41%	0.88%	0.54%	0.31%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	22.98	32.89	35.65	38.16	60.13	94.39
Forward PE	19.69	23.38	18.79	19.39	44.82	75.64
P/FCF Ratio	16.70	33.70	56.66	85.90	151.96	92.34
PS Ratio	2.29	3.10	3.13	5.04	12.61	20.25

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error